Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure

NCT02357615 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: nifedipine CR tablets (Xin Ran)
DRUG: Adalat

Sponsor

Shanghai Shyndec Pharmaceutical Co., Ltd.